wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57569610-DE2435AC-D566-4866-9960-12B67A886408
Q57569610-DE2435AC-D566-4866-9960-12B67A886408
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57569610-DE2435AC-D566-4866-9960-12B67A886408
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
P2860
Q57569610-DE2435AC-D566-4866-9960-12B67A886408
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57569610-DE2435AC-D566-4866-9960-12B67A886408
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b9515d20d1dd70e85bfdf268c3bfffe7cc3284ad
P2860
Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?